Status:
COMPLETED
Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial.
Lead Sponsor:
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
Conditions:
Retinopathy of Prematurity
Eligibility:
All Genders
3-3 years
Phase:
NA
Brief Summary
The retinopathy of prematurity (ROP) is a public health problem, the main causes of ROP are prematurity, use of oxygen, malnutrition and oxidative stress. Vitamin E was used beforehand however its use...
Detailed Description
Antioxidant defence mechanisms include cellular and extracellular enzymes. Vitamin E is the main fat-soluble vitamin responsible for the protection of cell membranes against peroxidation, thus, it pro...
Eligibility Criteria
Inclusion
- Newborn weight \< 1500 g
- Diagnosed respiratory distress syndrome (RDS)
- Patients who required mechanical ventilation or CPAP
Exclusion
- Congenital malformations
- Rh incompatibility
- Non-immune or immune hydrops fetalis
- Intraventricular haemorrhage III/IV grade
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03274596
Start Date
March 1 2013
End Date
December 1 2015
Last Update
September 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.